Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS

Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS

Secondary bacterial infection in COVID-19 patients is associated with increased mortality and disproportionately affects critically ill patients. This single-centre retrospective observational study investigates the comparative efficacy of change in procalcitonin (PCT) and other commonly available b...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Owen Richards, Philip Pallmann, Charles King, Yusuf Cheema, Charlotte Killick, Emma Thomas-Jones, Jessica Harris, Catherine Bailey, Tamas Szakmany
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
COVID-19
procalcitonin
C-reactive protein
secondary infection
Therapeutics. Pharmacology
RM1-950
Accès en ligne:https://doaj.org/article/81e29d712ba44af68bce49b9540bcb3f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/81e29d712ba44af68bce49b9540bcb3f

Documents similaires